ClinConnect ClinConnect Logo
Search / Trial NCT02640742

Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting

Launched by ASTRAZENECA · Dec 22, 2015

Trial Information

Current as of April 30, 2025

Completed

Keywords

ClinConnect Summary

Rationale for this Non-Interventional Study According to the Japanese Asthma Prevention and Management Guideline 2015 (Japan guideline (JGL) 2015), the goal in the management and treatment of asthma is "to be able to lead a life like a healthy individual." In order to achieve this therapeutic goal, the achievement of "well-controlled" state based on the asthma control status is considered to be a clinical goal. However, there are few studies in which the asthma control status is accurately surveyed in a real life setting in adult asthma patients receiving continued treatment from physician ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provided written consent before starting any procedure specified in the study protocol
  • Aged 20 years or older at the time of providing the consent
  • Receiving treatment for asthma as an outpatient at the time of providing the consent
  • Physician definitive diagnosis of asthma at least 1 year before providing the consent
  • Started to receive treatment with at least 1 of the following asthma drugs at least 1 year before providing the consent
  • Exclusion Criteria:
  • Enrolled in this study in the past
  • Assessed by the Investigator to require additional treatment due to worsening of asthma symptoms at the time of providing the consentEnrolled in this study in the past
  • Scheduled to be hospitalized within 2 weeks after providing the consent due to asthma or any other disease
  • Participating in another interventional study such as a clinical study at the time of providing the consent
  • Considered by the Investigator as not appropriate for enrollment in this study due to inability to adhere to the procedures, limitations, and requirements of this study including answering and returning the questionnaires, etc.

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Fujisawa, Kanagawa, Japan

Moriguchi, Osaka, Japan

Iwata, Shizuoka, Japan

Sendai, Miyagi, Japan

Fukuoka, , Japan

Kiyose, Tokyo, Japan

Kobe, Hyogo, Japan

Hamamatsu, Shizuoka, Japan

Yokohama, Kanagawa, Japan

Yokohama, Kanagawa, Japan

Shizuoka, , Japan

Fukuoka, , Japan

Okawa, Fukuoka, Japan

Saga, , Japan

Komaki, Aichi, Japan

Toyota, Aichi, Japan

Hachinohe, Aomori, Japan

Chikushino, Fukuoka, Japan

Kurume, Fukuoka, Japan

Kurume, Fukuoka, Japan

Kurume, Fukuoka, Japan

Omuta, Fukuoka, Japan

Omuta, Fukuoka, Japan

Yanagawa, Fukuoka, Japan

Date Gun, Fukushima, Japan

Mizunami, Gifu, Japan

Takasaki, Gunma, Japan

Sapporo, Hokkaido, Japan

Himeji, Hyogo, Japan

Kobe, Hyogo, Japan

Morioka, Iwate, Japan

Sakaide, Kagawa, Japan

Takamatsu, Kagawa, Japan

Takamatsu, Kagawa, Japan

Yokohama, Kanagawa, Japan

Yokohama, Kanagawa, Japan

Fukuoka, Koga, Japan

Tsukubo Gun, Okayama, Japan

Higashi Osaka, Osaka, Japan

Ikeda, Osaka, Japan

Takatsuki, Osaka, Japan

Takatsuki, Osaka, Japan

Cyuo Ku, Tokyo, Japan

Itabashi Ku, Tokyo, Japan

Koganei, Tokyo, Japan

Nakano Ku, Tokyo, Japan

Ota Ku, Tokyo, Japan

Shinjyuku Ku, Tokyo, Japan

Sumida Ku, Tokyo, Japan

Tachikawa, Tokyo, Japan

Fukuoka, , Japan

Fukushima, , Japan

Hiroshima, , Japan

Hiroshima, , Japan

Hiroshima, , Japan

Osaka, , Japan

Saitama, , Japan

Patients applied

0 patients applied

Trial Officials

Mitsuru Adachi, MD, PhD, Professor

Principal Investigator

International University of Health and Welfare

Gen Tamura, MD, PhD, President

Principal Investigator

Airway Institute in Sendai Co., Ltd

Masanori Nishikawa, DM, PhD

Principal Investigator

Department of Respiratory Medicine, Fujisawa City Hospital

Soichiro Hozawa, MD

Principal Investigator

Hiroshima Allergy and Respiratory Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials